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Abstract
Background: We applied a combined experimental and computational approach to ascertain how
peptides interact with host and microbial membrane surrogates, in order to validate simulation
methodology we hope will enable the development of insights applicable to the design of novel
antimicrobial peptides. We studied the interactions of two truncated versions of the potent, but
cytotoxic, antimicrobial octadecapeptide protegrin-1, PC-72 [LCYCRRRFCVC] and PC-73
[CYCRRRFCVC].
Results: We used a combination of FTIR, fluorescence spectroscopy and molecular dynamics
simulations to examine the peptides' interactions with sodium dodecylsulfate (SDS) and
dodecylphosphocholine (DPC) micelles. The relative amounts of secondary structure determined
by FTIR agreed with those from the simulations. Fluorescence spectroscopy, deuterium exchange
experiments and the simulations all indicate that neither peptide embeds itself deeply into the
micelle core. Although molecular simulations placed both peptides at the micelle-water interface,
further examination revealed differences in how certain residues interacted with the micelle core.
Conclusion: We demonstrate here the accuracy of molecular dynamics simulations methods
through comparison with experiments, and have used the simulation results to enhance the
understanding of how these two peptides interact with the two types of micelles. We find
agreement between simulation and experimental results in the final structure of the peptides and
in the peptides final conformation with respect to the micelle. Looking in depth at the peptide
interactions, we find differences in the interactions between the two peptides from the simulation
data; Leu-1 on PC-72 interacts strongly with the SDS micelle, though the interaction is not
persistent – the residue withdraws and inserts into the micelle throughout the simulation.
1. Background
Antimicrobial peptides (AMPs) are produced by many, if
not all, plants and animals [1-3]. Despite over two dec-
ades of study, the mechanism of action of AMPs against
cellular and microbial membranes is not entirely clear,
hindering efforts to design novel, non-toxic antimicrobial
peptides [4]. Many AMPs target the membrane lipid
bilayer, as evidenced by experiments showing that their
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presence increases the rate of internal leakage from syn-
thetic liposomes. Furthermore, enantiomeric versions of
many AMPs are as active as their native counterparts, sug-
gesting that stereospecific receptors are not the targets of
AMPs [5,6]. An important factor hindering development
of therapeutic AMPs is that many active antimicrobial
peptides also injure human cells, and thus would benefit
from structural modifications that reduce host-toxicity
levels without impairing their potency against pathogens.
We undertook this study believing that a combined exper-
imental and computational approach that clarifies how
peptides interact with mammalian host and microbial
membranes could be a valuable adjunct to AMP-design. It
may one day be possible to pinpoint sequence regions or
residues that contribute to peptide activity or toxicity by
examining the interactions of specific residues with mem-
brane mimics, though the study of numerous peptides
will be required to reach this goal. This study combines
experimental techniques such as Fourier-transform infra-
red spectroscopy (FTIR) with atomistic molecular dynam-
ics (MD) simulations to determine the validity of the
simulation methodology and to demonstrate the utility of
MD simulations in providing molecular level detail about
the interactions between the peptides and membrane
mimics. After confirming the accuracy of the simulations
by comparison with experimental data, we can begin to
examine the molecular level detail provided by the simu-
lations.
The protegrins are a family of five potent cationic antimi-
crobial peptides originally purified from porcine leuko-
cytes [7,8]. Protegrin (PG)-1 [RGGRL CYCRR RFCVC
VGR-amide] has a β-hairpin structure that is stabilized by
disulfide bonds linking Cys-6 to Cys-15, and Cys-8 to Cys-
13. The broad antimicrobial spectrum of PG-1 includes
Gram-positive and Gram-negative bacteria and certain
fungi [7,9]; however, PG-1 also damages human cells
[10], limiting its therapeutic potential. Hence, though the
potent antimicrobial properties of full-length PG-1 made
it a reasonable starting point for developing a therapeutic
AMP [11], its substantial cytotoxicity was problematic.
Indeed, the toxicity of Iseganan (IB-367, a protegrin-like
peptide [12]) may have contributed to the unsuccessful
outcome of clinical trials to evaluate its ability to prevent
oral mucositis and ventilator-associated pneumonia [12-
14].
The matter of rationally engineering peptides with antimi-
crobial yet non-toxic character thus remains open. This
study examines the differences between the interactions of
two peptides with two types of membrane mimics
through various experimental techniques and MD simula-
tions to determine whether the simulation methods accu-
rately capture the interactions between peptides and
micelles. PC-72 is a truncated, 11-residue version of PG-1
[LCYCR RRF CV C-amide] and PC-73 is a 10-residue pep-
tide that is identical to PC-72, except for the absence of its
N-terminal leucine. The disulfide bond patterns in PC-72
and PC-73 are identical to those in PG-1.
Ideally in the study of AMPs, the interactions of multiple
peptides with a lipid bilayer of similar composition to the
human or bacterial cell membrane would be examined.
Since bilayers pose difficulties with traditional experimen-
tal techniques like FTIR and NMR, and due to significant
methodological bottlenecks for simulations of peptides
with lipid bilayers, we propose to work with micelles as
membrane mimics. Micelles provide a minimalistic sys-
tem for the study of activity and toxicity; like lipid bilay-
ers, micelles possess a well-defined hydrophobic core and
a flexible, hydrophilic interface and are commonly used
in place of monolayers or bilayers in experimental meth-
ods such as NMR spectroscopy [15-18]. Recently, studies
of a variety of AMPs including, piscidin, magainin, and
aurein, have been conducted in micelles [19-24]. Impor-
tantly, they have faster time scales of motion [25-30] and
smaller system size, which reduce the required simulation
length to one that is computationally feasible. DPC
micelles simulate eukaryotic cell membranes, which are
generally rich in zwitterionic phospholipids. SDS mimics
the negatively charged molecules found in bacterial mem-
branes [31], because it has a flexible, anionic exterior and
a hydrophobic interior [32-36]. We have previously stud-
ied other AMPs, including protegrin-1 and indolicidin, in
SDS and DPC micelles [11,37-42].
We should stress that micelles are not appropriate vehicles
for clarifying all the relevant phenomena involved in bio-
logical function and pharmacological profiles. Nonethe-
less, we believe it is a reasonable hypothesis to relate the
activity and toxicity of peptides to binding with bacterial
and mammalian membrane mimics. One cannot over-
look the fact that the peptides need to first bind to the
membrane. This is step number one in a cascade of steps
that is not entirely clear and may indeed involve the aggre-
gation of multiple peptides to form pore-like structures.
What we can try to determine is whether this initial bind-
ing is important and to what extent. The present study
provides a basis for the use of our simulation methods,
which will allow us to continue to investigate this matter.
2. Results and discussion
Depth of insertion
Deuterium exchange experiments were carried out to pro-
vide information on the solvent accessibility of the pep-
tides in the two micellar environments. Peptide residues
exposed to solvent will exchange very rapidly compared to
residues that are buried in more hydrophobic domains of
the peptide-micelle ensemble. Both PC-72 and PC-73BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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deuterated rapidly in the first few minutes of exposure to
the solvent. There were no significant differences between
the two peptides with regard to the rapid deuteration in
either of the micellar systems used in this study. The ready
exchange of the micelle-bound PC-72 and PC-73 peptides
is more consistent with a position on the solvent-accessi-
ble surface of the micelles, rather than enclosure within
the hydrophobic interior of the micellar ensemble.
The fluorescence emission of tyrosine was also used to
assess the peptides' molecular topography in the micellar
systems of SDS and DPC. Tyrosine fluorescence of PC-72
and PC-73 in SDS and DPC centered around 305 nm and
had a spectrum (data not shown) that is the same as the
peptides in PBS solution alone. This finding suggests that
when the peptides are bound to DPC or SDS micelles the
tyrosine residue in the amino acid sequence is in an aque-
ous bulk solution accessible environment. As discussed
below, this is consistent with the MD simulations results
that show this residue is near the micelle-water interface
and bulk solvent accessible.
The depth of insertion of the peptides into the micelles
was explored using the molecular dynamics simulation
data as well. We began by examining the final, equilib-
rium conformations of the systems. In figure 2 and 3, final
images from the simulations are shown. Visual inspection
indicates good agreement between the H/D data and the
results of the simulations. In both types of micelles the
peptides move to the micelle-water interface, though in
each system certain residues are seen to insert into the
micelle core. In Figure 2, PC-72 is seen to be located near
the DPC-aqueous interface, allowing Tyr-3 to interact with
the hydrophobic micelle core and the bulk water. Val-10
and Phe-8 also interact with micelle interface. PC-73
appears to hover just at the interface between the water
and micelle surface, with the hydrophobic face of the pep-
tide facing towards the micelle, but not embedded in the
core.
In the SDS micelles (Figure 3), PC-72 appears to be tilted
at the end of the simulation to allow interactions between
Phe-8 and Val-10 and the micelle. In this snapshot from
the simulation, Leu-1 and Tyr-3 are not interacting with
the micelle. PC-73 shows some insertion of Phe-7 and
Val-9 into the SDS micelle core.
The distance between the center of mass of the micelle and
the center of mass of the peptide was computed for each
system, and the results (Figure 4) provide a way to quan-
tify the images in Figures 2 and 3. We also use this meas-
urement as a way to determine when the system has
reached equilibrium. In nearly all of the simulations, the
peptide reached its equilibrium position with respect to
the micelle center of mass within 10 ns, though PC-73 in
DPC required nearly 15 ns to equilibrate. There was no
Kinetics of PC-72 and PC-73 deuteration in DPC (A) and SDS (B) micelles Figure 1
Kinetics of PC-72 and PC-73 deuteration in DPC (A) and SDS (B) micelles.   The percent peptide deuteration was estimated 
from the area of the amide   II bands as described in MethodsBMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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Final views from the simulations in DPC micelles (water removed for clarity) Figure 2
Final views from the simulations in DPC micelles (water removed for clarity). On the left is PC-72, shown in orange, and on the 
right PC-73, shown in yellow. The hydrophobic residues are colored for emphasis: leucine in red, tyrosine in green, phenyla-
lanine in blue, and valine in violet. In the final conformation for each simulation the peptide is located at the micelle-water inter-
face.
Final views from the simulations in SDS micelles (water removed for clarity) Figure 3
Final views from the simulations in SDS micelles (water removed for clarity). On the left is PC-72, shown in orange, and on the 
right PC-73, shown in yellow. The hydrophobic residues are colored for emphasis: leucine in red, tyrosine in green, phenyla-
lanine in blue, and valine in violet. Visual inspection suggests that PC-72 is slightly more deeply inserted into the SDS micelle.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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discernible difference between the distance from the
center of mass of PC-72 and PC-73 in the SDS micelle. Of
course, measurements that are based only on the peptide
center of mass cannot convey the subtleties of differences
in orientation and interaction for these two peptides rela-
tive to the micelles.
The simulations can also provide solvent exposed surface
area data for each peptide in each system; we calculated
the percentage of the peptide surface exposed to water.
The solvent exposed surface area calculated is the Lee-
Richards surface area with a probe radius of 1.6 and accu-
racy set to 0.05 [43]. The results of these calculations are
plotted in figure 5 and provide a consistent picture with
the H/D exchange data presented earlier: no significant
difference between the exposed areas can be detected
among the systems.
In order to better understand the subtleties of the position
of the individual residues in the micelle, we calculated the
distance between the center of mass of the micelle and
each residue. For most residues, the relative position of
the residue was constant over the period of the simulation
in which the peptide has reached its final conformation,
with the exception of Leu-1 on PC-72 when interacting
with the SDS micelle. In figure 5 we plotted the movement
of this residue and show that it moves periodically in and
out of the micelle. This is not visible in Figure 2, which
shows only the final configuration at 30 ns into the simu-
lation. In Figure 6 we can see that the N-terminus of this
peptide interacts intermittently with the micelle core.
Secondary structure
Analysis of the dihedral angles from the simulations was
used to confirm that a stable, steady-state conformation
has been obtained. One would not expect substantial flex-
ibility in the structure of these small, β-hairpin peptides
that are constrained by two cysteine-cysteine disulfide
bonds, and indeed we see deviations in the value for each
dihedral angle to be on the order of 5 to 10 degrees for all
of the residues, except for the Ψ angle involving Leu-1 on
PC-72 in both SDS and DPC, which exhibit deviations of
around 20 degrees. Given that this residue is at the N-ter-
minus, these variations in the angles are not unreasona-
ble.
FTIR measurements of PC-72 and PC-73 peptides were
performed in DPC and SDS to provide estimates of the
secondary structure of these peptides in each micellar sys-
tem. Both PC-72 and PC-73 have similar spectral signa-
tures in DPC micelles at a mole ratio of 1:60 peptide to
lipid. There are two major dominant absorption peaks at
1674 and 1638 cm-1 that are typical of peptides assuming
loop-turn and β-sheet conformations in the micellar envi-
Plots of the distance between the center of mass of the  micelle and center of mass of the peptide Figure 4
Plots of the distance between the center of mass of the 
micelle and   center of mass of the peptide.  There is no visi-
ble difference for the   peptides in DPC (A) or in SDS (B) 
micelles, in agreement with the H/D   exchange data.
Plot of the percentage of solvent (water) exposed peptide  surface area Figure 5
Plot of the percentage of solvent (water) exposed peptide 
surface area. There are no significant differences between the 
two peptides in either micelle, in agreement with the H/D 
exchange data.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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ronment. The absorbance peaks for β-sheet are broad with
a Full Width at Half Maximum (FWHM) of approximately
12 cm-1 indicating that there is a mix of parallel and anti-
parallel conformations of the micellar bound peptides.
Analysis of the simulation dihedrals for the peptides con-
firm both the total percent β-sheet as well as the relative
contributions of parallel and anti-parallel β-sheet mix of
conformations observed in the FTIR measurements (Table
3). The overall percent conformations from β-sheet, loop-
turn, helical and disordered conformation also compare
reasonably well with those estimated from molecular sim-
ulations of both peptides in DPC micelles. PC-72 consist-
ently showed slightly more β-sheet conformers relative to
loop-turn structures compared with PC-73 in DPC
micelles.
Analysis of PC-72 and PC-73 in SDS micelles showed sim-
ilar percentages of the various conformations as observed
with DPC; however, the β-sheet absorption peak shifted
from 1638 cm-1 to 1629 cm-1  and became narrower
(FWHM ~8 cm-1) suggesting a greater proportion of anti-
parallel β-sheet (Figure 8). There was also a clear high fre-
quency band centered around 1689 cm-1. This is the sig-
nature of frequency splitting of the peptide amide I band
into high and low frequency components associated with
anti-parallel  β-sheets and confirms the presence of a
greater population of anti-parallel β-sheet conformations
in the SDS micellar environment [44]. Both FTIR meas-
urements and MD simulations suggest that the PC-72 and
PC-73 peptides in SDS assume β-sheet anti-parallel con-
formations to a greater degree than parallel β-sheet. The
PC-72 congener has a greater amount of antiparallel β-
sheet at the expense of loop-turn conformations than the
PC-73 peptide in the SDS micellar environment.
Strength of interaction
For more detailed information about the interactions
between the peptides and micelles, radial distribution
functions (RDFs) were calculated from the simulation tra-
jectories. RDFs were calculated for each residue side chain
with the SDS and DPC micelle cores. Radial distribution
Views of the PC-72 in SDS micelle (water not shown) Figure 7
Views of the PC-72 in SDS micelle (water not shown). From the images it is clear that the leucine residue has come out of the 
micelle and is away from the interface as 17 ns, but attractions to the micelle core pull it back in by 22 ns. Leu-1 moves back 
out of the micelle by the conclusion of the simulation at 30 ns.
Distance between the leucine residue and the micelle center  of mass Figure 6
Distance between the leucine residue and the micelle center 
of mass. It is clear that the position of Leu-1 is fluctuating, 
moving from its inserted position at 11 ns, and then returning 
at 20 ns. Because this residue is at the N-terminus, it is not 
anchored to the interface by proximity to arginine groups 
like Phe-8.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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functions tell how likely it is that a certain type of atom
will be found in a given distance from another specific
atom or atom group, thus giving relative affinities
between sets of atoms in the system. A sharper, larger peak
indicates stronger interaction.
It can be informative to integrate the area under the plots
to determine an overall strength of interaction. Compar-
ing the totals of the integration of all of the residues we
find that the sum for PC-72 in SDS (when Leu-1 is
inserted into the core) is 54.8, larger than the sum for PC-
73, 39.3. In DPC, there is a less significant difference, the
peaks total 49.7 for PC-72 and 41.1 for PC-73.
There are several residues that show strong interactions
with the SDS micelle core. Leu-1 on PC-72 has a large
peak, when calculated during the "inserted" time period,
suggesting that it is of importance for this peptide's activ-
ity. The neighboring Cys-2 residue also exhibits a strong
peak, thereby signifying the importance of the N-terminus
FTIR spectra of PC-72 (A) and PC-73 (B) in SDS micelles Figure 9
FTIR spectra of PC-72 (A) and PC-73 (B) in SDS micelles.
FTIR spectra of PC-72 (A) and PC-73 (B)  in DPC micelles Figure 8
FTIR spectra of PC-72 (A) and PC-73 (B) in DPC micelles.  
PC-72 shows   slightly more beta-sheet conformers relative 
to loop turn structures than   PC-73.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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Radial distribution functions for PC-72 (A) and PC-73 (B) with the micelle cores Figure 10
Radial distribution functions for PC-72 (A) and PC-73 (B) with the   micelle cores.  There are few differences between the 
RDFs for PC-72 and   PC-73 in DPC.  In SDS, there is a strong peak for Leu-1 for the 20ns to   25ns time period (in green), 
suggesting that this residue is responsible   for the activity of this peptide, though it is not constantly inserted   into the micelle.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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in interactions with the negatively charged micelle. There
are strong peaks for Phe-8 and Val-10 on with the SDS
micelle as well, though they are not much more signifi-
cant than the peaks from the corresponding residues on
PC-73.
In comparing the two peptides interactions with DPC, we
see few differences for each residue. There are slightly
stronger interactions around Arg-5 on PC-72 and slightly
stronger interactions at Phe-7 on PC-73, but the differ-
ences offset each other, as evidenced by the integration
results.
If we contrast the interactions of PC-72 with both types of
micelles, we see a clear difference in the interactions of
Tyr-3 and, most notably, a distinct lack of peak for Leu-1
on PC-72 with DPC. The RDF for Leu-1 on PC72 fluctu-
ates, and is shown for the period around 22 ns (the higher
peak) and for the last 5 ns of the simulation (the lower
peak). Tyr-3 has little interaction with the SDS micelle
core, but has a much stronger peak with the DPC micelle
core. This appears to be at odds with the fluorescence data
discussed previously; however, it can be explained by the
images in figure 2 and 3, which show how Tyr-3 is inter-
acting with the micelle core, but is also exposed to the
water.
3. Conclusion
We have presented the results of detailed investigations
into four systems: two related peptides in SDS and DPC
micelles, using a combination of experimental techniques
and molecular dynamics simulations. We see that the sim-
ulation results complement the experimental results. In
comparing the FTIR and the simulation results, we see that
the peptides are adopting similar conformations in the
experimental setting as in the simulations. This assuages
some of the concerns about the ability of the relatively
short time scale of the simulations to capture the proper
peptide structures. Additionally, from the deuterium
exchange data, it appears that the peptides all position
themselves at the surface of the micelle, where they can
interact with both the micelle core and the bulk water.
From the fluorescence data, it seems that Tyr-3 on PC-72
(and Tyr-2 on PC-73) is able to interact with the bulk
water when interacting with both types of micelle.
Though the radial distribution function for Tyr-3 on PC-
72 when interacting with DPC has a high peak, we can
inspect the system visually and see that though Tyr-3 is in
contact with the micelle core, it is also exposed to the
water subphase.
Of particular note in this study is the observed difference
in the interactions of the N-termini of PC-72 and PC-73
with the SDS micelle in the simulation, differences that
could not be observed from experiments. Though there is
little difference in the experimental data between the two
peptides when interacting with the SDS micelles, we do
find that the leucine residue on PC-72 is interacting with
the micelle core, albeit intermittently.
The agreement between the experimental and simulation
data demonstrates the validity of the simulation methods
for investigating the interaction between peptides and
micelles. Additionally, the simulations provide the neces-
sary level of detail to determine differences in the ways in
which the peptides interact with the two types of micelles
and knowing that the simulation results agree with exper-
imental results, we can then extend the analysis of the
simulations to explore the systems in more detail. This
work is a necessary step in the overall goal of developing
simulation methods to determine activity and toxicity of
peptides a priori, though the methods must be developed
through the study of more peptides. It would be prema-
ture to base conclusions about the effectiveness of the
micelles as membrane environments based on two data
points, PC-72 and PC-73.
Table 2: Average dihedral angles for PC-73 over the last 5 ns of 
simulation with deviation in parentheses
DPC SDS
ΦΨ Φ Ψ
1 0 167.9 (7.8) 0 155.0 (13.4)
2 -97.9 (7.0) 93.7 (5.1) -115.5 (15.6) 136.5 (10.8)
3 -97.5 (4.7) 135.4 (6.5) -105.3 (14.7) 131.4 (8.8)
4 -109.0 (5.8) -144.2 (9.7) -96.2 (8.7) -74.1 (7.7)
5 -83.1 (9.1) -56.1 (5.1) -102.0 (7.6) -99.5 (10.3)
6 -86.8 (6.1) -57.8 (6.7) -102.3 (9.6) -60.0 (4.7)
7 -105.7 (7.6) 164.4 (5.0) -88.1 (5.7) 121.6 (8.7)
8 -135.7 (5.4) 132.2 (5.3) -94.6 (6.7) 69.2 (9.6)
9 -109.3 (6.3) 120.7 (5.8) -91.6 (8.2) 130.7 (8.8)
10 -100.8 (5.7) 0 -116.1 (12.5) 0
Table 1: Average dihedral angles for PC-72 over the last 5 ns of 
simulation with deviation in parentheses
DPC SDS
ΦΨΦΨ
1 -176.3 (25.0) 144.9 (18.6)
2 -97.9 (8.5) 159.7 (12.2) -82.3 (8.2) 130.5 (10.3)
3 -102.0 (7.1) 93.7 (7.1) -125.0 (11.9) 165.5 (6.2)
4 -102.3 (4.9) 148.2 (11.6) -108.3 (9.6) 136.5 (8.29)
5 -137.2 (11.4) -79.0 (5.9) -93.1 (6.2) -79.6 (9.2)
6 -109.1 (6.9) -84.0 (5.9) -103.6 (8.0) -94.9 (7.9)
7 -103.8 (6.9) -66.1 (4.6) -99.7 (8.0) -60.3 (4.5)
8 -84.0 (5.0) 133.7 (8.3) -86.6 (5.0) 109.8 (7.0)
9 -114.2 (9.3) 134.7 (8.3) -92.1 (5.3) 73.3 (9.0)
10 -104.9 (7.0) 121.1 (9.3) -102.5 (9.1) 133.8 (8.5)
11 -105.5 (8.0) -105.6 (10.0)BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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4. Methods
4.1 Peptide synthesis and purification
PC-72 and PC-73 were synthesized on a 0.25 mmole scale
with an Applied Biosystems 431A peptide synthesizer
using FastMoc™ chemistry [45], double coupling, and
Rink amide MBHA resin (Novabiochem, San Diego, CA).
The cleaved peptide was deprotected with a solution of tri-
fluoroacetic acid:ethanediothiol:thio-
anisole:water,10:0.25:0.5:0.5, v:v for 2 hours, followed by
precipitation with cold t-butyl ether. After drying under
vacuum, the precipitate was reduced with Tris(2-carboxye-
thyl)phosphine hydrochloride (TCEP, Pierce, Rockford,
IL), and purified by reverse phase HPLC on a C18 column
(Vydac, Hesperia, CA) using a linear gradient of water:ace-
tonitrile with 0.1% TFA as an ion pairing agent. Folding
(air oxidation) of the purified, reduced peptide (0.1 mg
peptide/ml buffer) was done in 5 mM ammonium acetate
buffer pH 7.5 for 48 hours at 25°C with stirring. The oxi-
dized peptide was purified by the above HPLC procedure
and its mass was confirmed by MALDI MS. Peptides were
twice freeze-dried from 10 mM HCl to remove residual tri-
fluoroacetate counter ions that would interfere with FTIR
measurements.
4.2 Fluorescence measurements of tyrosine fluorescence in 
micelles
Steady-state fluorescence emission spectra of tyrosine res-
idues in PC-72 and PC-73 were made at 25°C, in DPC and
SDS micelles, with a Cary Eclipse Fluorescence spectro-
photometer at an excitation wavelength of 274 nm. The
molar ratio of peptide to SDS (Sigma, St. Louis, MO) or
DPC (Avanti Polar Lipids, Alabaster, AL) was ~1:60. Rea-
gents were prepared in a buffered saline solution (8.1 g/L
NaCl with 0.6 g/L K2HPO4, pH 7.5; Mediatech, Herndon,
VA) that closely matched the simulation conditions.
4.3 FTIR measurements of peptide conformation and 
hydrogen-deuterium exchange
Infrared spectra were recorded at 25°C using a Vector 22
FTIR spectrometer (Bruker Optics, Ettingen, Germany)
equipped with Deuterated Triglycine Sulfate (DTGS)
detector, averaged over 256 scans at a gain of 4 and a res-
olution 2 cm-1. To obtain Fourier-transform infrared
(FTIR) spectra of PC-72 and PC-73 peptides in SDS or
DPC micelles, the micelle preparations (peptide:SDS/
DPC molar ratio ~1:60) were allowed to form a film by air
drying the aqueous dispersion on 50 × 20 × 2 mm 45°
attenuated total reflectance (ATR) crystals fitted for the
Vector 22 spectrometer (Pike Technologies, Madison, WI,
USA). The sample was then hydrated by passing deute-
rium vapor in nitrogen gas over the film one hour prior to
measurement.
The amide I bands of FTIR spectra of the PC-72 and PC-73
peptides were analyzed for various secondary conforma-
tions [27]. The proportions of α-helix, β-turn, β-sheet, and
disordered conformations were determined by Fourier
self-deconvolutions for band narrowing and area calcula-
tions of component peaks determined with curve-fitting
software supplied by Galactic Software. The frequency
limits for the different structures were as follows: α-helix
(1662 to 1645 cm-1), β-sheet (1643 to 1623 and 1695 to
1685 cm-1), β-turns (1682 to 1662 cm-1) and disordered
or random (1650 to 1637 cm-1) [46]. Although anti-par-
allel beta sheets have low frequency amide I band cen-
tered around 1630 cm-1 and a less intense high frequency
signature band in the range of 1685 to 1695 cm-1, parallel
beta sheet amide I bands are less definitive [37]. Recent
studies of proteins with a large proportion of parallel beta
strands suggest that the amide I absorption for this confor-
mation is centered about 1638 cm-1 and therefore can
Table 3: Proportions of secondary structure in micelles for PC-72 and PC-73 from FTIR spectra and molecular dynamics simulations*. 
Data are the mean of 5 separate determinations.
Sample % Beta sheet %Loop-turn %Disordered %Helix
PC-72 SDS FTIR 43.3 42.3 4.4 10.0
PC-72 SDS Simulation 52.0 27.2 14.4 6.4
PC-72 DPC FTIR 54.0 30.8 10.2 5.0
PC-72 DPC Simulation 54.2 27.4 9.3 9.1
PC-73 SDS FTIR 23.4 48.1 18.5 10.0
PC-73 SDS Simulation 40.0 29.0 20.0 11.0
PC-73 DPC FTIR 38.6 46.1 6.3 9.0
PC-73 DPC Simulation 43.0 27.0 15.0 15.0
*The percentage residue specific anti-parallel and parallel beta sheet conformations were determined from peptide simulation structures using the 
Hyperchem 7.5 secondary structure analysis utility. This utility classifies anti-parallel beta sheet as residues having dihedral angles of Φ = -139° and 
ψ = 135° and parallel beta sheet as residues having dihedral angles of Φ = -119° and ψ = 113°. The values in the above table represent the sum of 
residues participating in anti-parallel and parallel beta sheet structures for a given peptide in a specific environment. Similar analysis procedures 
were used for helix and random conformations. Loop structure percentages were based on the residues participating in disulfide stabilized loop 
sequence since there is no specific secondary structure classification for this motif in the analysis utility.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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overlap contributions from the anti-parallel amide I
absorbance [47] making spectral deconvolution of these
two conformations problematic. For this reason we report
the overall integration of the spectral region from 1643 to
1623 cm-1 as β-sheet conformations that includes both
parallel and anti-parallel conformations.
The time course of deuterium exchange was determined
by subjecting the peptide-micelle films in the sealed ATR
sample chamber described above to a stream of D2O-sat-
urated nitrogen gas. The course of sample deuteration was
monitored by acquiring FTIR spectra at various time
points over the period of one hour. The relative area of the
amide II band between 1596 and 1502 cm-1 was used as
an index of the degree of sample deuteration.
4.4 Molecular dynamics simulations
Simulations of PC-72 and PC-73 in SDS and DPC micelles
were carried out as previously described [48,49]. Struc-
tures for PC-72 and PC-73 were created by homology
modeling as described in [50]. Briefly, the known struc-
ture for PG-1 was imported into MOE [51] and the N- and
C-termini were removed and the structure minimized
using the AMBER89 forcefield. Once imported into
CHARMM, the C-terminus is amidated. Because these two
peptides are small (10 and 11 residues), and their
sequences are identical with the corresponding protegrin-
1 regions, and they are constrained by the same two
disulfide bonds, we can be confident that the structures
from homology modeling with a protegrin-1 template are
very close to the actual structures; that is, that they adopt
the cysteine-cysteine constrained β-hairpin structure.
The starting coordinates of the SDS micelle-water complex
were taken from simulations carried out by MacKerell
[52]. The SDS micelle was composed of 60 molecules and
solvated in a cube with 54.15Å long sides that contained
4375 water molecules. In previous simulations of prote-
grins with the DPC micelle, we saw the separation of one
molecule of DPC from the micelle, suggesting a lower Nag-
gregation than in the original 60 molecule DPC micelle. To
correct for this, one molecule was removed from the
micelle resulting in a micelle composed of 59 DPC mole-
cules. Due to the slightly larger size of a DPC molecule
versus SDS, the DPC micelle was solvated in a rhombic
dodecahedron containing 6120 water molecules. In creat-
ing a larger simulation box, the goal was to increase the
distance between the system and the edges of the box
without increasing the number of water molecules neces-
sary to solvate the box unnecessarily. The rhombic dodec-
ahedron geometry allows a thicker layer of water around
the micelle while increasing the actual number of atoms
that must be simulated within a reasonable amount. In
both cases, the cell dimensions were set to obtain the
equilibrium bulk water density away from the micelle
interface of 0.033/Å 3 and as we have seen, the surfactant
molecules are able to rearrange themselves as necessary to
accommodate changes in the aggregation number due to
the presence of the peptide. The choice of using a pre-
formed micelle with a set aggregation number is justified
by scores of simulations of peptides in micellar systems
conducted, obtaining microseconds of trajectories in total
[11, 37, 38, 39, 40, 41, 42, 48, 49, 60]. During all these
simulations we have only observed the departure of a sin-
gle DPC molecule from a micelle composed of 60 mole-
cules. If the systems were not at equilibrium, even rare
occurrences of destabilization would have been observed
more than once. We thus feel confident that our system is
with the range of aggregation numbers for DPC-peptide
and SDS-peptide systems. Water was modeled using the
TIP3P potential [53]. NaCl ions at a concentration of 0.15
M were randomly distributed in the aqueous phase for the
SDS and the DPC simulations.
In all simulations, the peptide was initially placed in the
center of the micelle core with the micelle center of mass
overlapping the peptide's center of mass. Given the spher-
ical symmetry of the micelle, the orientation of the pep-
tide is unimportant. The system is inspected visually to
ensure that no serious overlaps occur. Then, to further
remove initial bad contacts between the peptide and the
core, and to prevent penetration of water during equili-
bration, the system was minimized with the peptide and
bulk water initially kept under weak harmonic constraints
with spring constants of 10 and 5 kcal/mol Å, respectively.
The constraints were gradually removed in 20,000 steps of
minimization, using the steepest descent method. The
entire system was then minimized for 20,000 additional
steps, without constraints. Thereafter, the system, consist-
ing of approximately 16,000 atoms, was gradually heated
to 303.15 K. After 500 ps of equilibration, the entire
assembly was subjected to NPT dynamics at a pressure of
1 atm and a temperature of 303.15 K. The constant pres-
sure-temperature module of CHARMM was used for the
simulations with a leap-frog integrator (2 fs time step).
The temperature was set at 303.15 K using the Hoover
temperature control [54]. All the components of the pis-
ton mass array were set to 500amu for the extended sys-
tem pressure algorithm [55,56]. The electrostatic
interactions were simulated using the particle mesh Ewald
(PME) summation[57] without truncation and a real
space Gaussian width of 0.25 Å -1, a β-spline order of 4,
and a FFT grid of about one point per Angstrom. All sim-
ulations were carried out using CHARMM version c30b2
with the param22 parameter set [58]. The CHARMM pro-
gram, and its force field and parameters are described in
detail by both Brooks [58] and MacKerell et al [59]. Sim-
ulations were stopped approximately 10 nanoseconds
after the peptide showed no change in its location from
the center of the micelle.BMC Biochemistry 2007, 8:11 http://www.biomedcentral.com/1471-2091/8/11
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MD, molecular dynamics; AMPs, antimicrobial peptides;
CHARMM, Chemistry at Harvard Macromolecular
Mechanics; PG-1, protegrin-1; SDS, sodium dodecylsul-
fate; DPC, dodecylphosphocholine, FWHM, full width at
half maximum of the FTIR spectral band
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